About OCC
Orthocell Limited (OCC) operates as a regenerative medicine company engaged in developing products for the repair of bone and soft tissue injuries. The company has appointed a network of specialist distributors in the United States and recorded initial sales. The company's nerve repair product holds approval in Australia, New Zealand and Singapore and is distributed through Device Technologies Group in those markets.
Find out what a historical investment in Orthocell would be worth today using our OCC stock calculator.
Market Capitalisation
$187.95M
Price-earnings ratio
-13.11
Dividend yield
-
High today
$0.71
Low today
$0.69
Open price
$0.70
52-week high
$1.51
52-week low
$0.67
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in OCC
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in OCC on Stake
- Buy OCC from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
OCC related stocks